FTC Asks for More Info to Review UnitedHealth, DaVita Deal
March 13 2018 - 7:34AM
Dow Jones News
By Allison Prang
The U.S. Federal Trade Commission has asked for more information
regarding UnitedHealth Group's (UNH) proposed deal to buy DaVita
Medical Group (DVA), DaVita Inc. said in a regulatory filing.
DaVita said that the FTC asked for more information on March 12
to review the deal, which still needs regulatory approval.
UnitedHealth's $4.9 billion cash deal to buy DaVita Medical
Group was announced in December and would combine the group with
the OptumCare division a part of Optum, which is part of
UnitedHealth.
Shares of UnitedHealth and DaVita were flat premarket.
Write to Allison Prang at allison.prang@wsj.com
(END) Dow Jones Newswires
March 13, 2018 07:19 ET (11:19 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
DaVita (NYSE:DVA)
Historical Stock Chart
From Aug 2024 to Sep 2024
DaVita (NYSE:DVA)
Historical Stock Chart
From Sep 2023 to Sep 2024